Genetic abberations in gallbladder cancer (Q37794438)

23 August 2017

title

Genetic aberrations in gallbladder cancer (English)

1 reference

23 August 2017

Genetic abberations in gallbladder cancer (English)

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

23 July 2024

main subject

tumor suppressor gene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880699

23 July 2024

author name string

Mallika Tewari

2

1 reference

23 August 2017

Hari S Shukla

4

1 reference

23 August 2017

Sanjeev K. Maurya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880699

23 July 2024

Raghvendra R. Mishra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880699

23 July 2024

Raghvendra R. Mishra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880699

23 July 2024

Hari S. Shukla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880699

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20880699

23 July 2024

publication date

29 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0960740410000812?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

https://api.elsevier.com/content/article/PII:S0960740410000812?httpAccept=text/plain

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

23 July 2024

1 reference

23 August 2017

volume

21

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

37-43

1 reference

23 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients

23 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

23 July 2024

Gallbladder cancer

3

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Gallstones and the risk of biliary tract cancer: a population-based study in China

23 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification

23 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

23 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.

23 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

A clinico-pathological study of carcinoma of the gall bladder

23 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Carcinoma of the gallbladder. The Roswell Park experience.

23 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy

23 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

What causes cancer gallbladder?: a review

23 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Preneoplastic lesions in gallbladder cancer

23 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary

23 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Cellular kinetics and gene mutations in gallbladder mucosa with an anomalous junction of pancreaticobiliary duct

23 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

High frequency of p53 gene mutation in adenocarcinomas of the gallbladder

23 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma

23 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis

23 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.

23 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma

23 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma

23 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas

23 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Two distinct pathways of p16 gene inactivation in gallbladder cancer

23 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer.

23 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Frequency of K-ras mutation in biliary and pancreatic tumors

23 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer.

23 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers

23 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.

23 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells

23 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder

23 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

EGFR and HER2 expression in advanced biliary tract cancer

23 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.

23 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer

23 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

23 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Systemic therapy for biliary tract cancers

23 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Phase II study of erlotinib in patients with advanced biliary cancer

23 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

23 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma

23 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax

23 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene.

23 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Cyclin E overexpression in human gallbladder carcinomas

23 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Cyclin E expression in benign and malignant epithelial neoplasms of the gallbladder

23 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis.

23 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma

23 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

CD44 (HCAM) expression in subserous gallbladder carcinoma

23 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis

23 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

MUC 1 core protein as a marker of gallbladder malignancy.

23 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder

23 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder

23 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.

23 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder.

23 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma

23 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes

23 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

23 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer

23 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases

23 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

The role of estrogen receptors in the development of gallstones and gallbladder cancer

23 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer

23 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma

23 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux

23 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Here, there, and everywhere: kinetochore function on holocentric chromosomes

23 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Expression of human telomerase catalytic protein in gallbladder carcinogenesis

23 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Genetic alterations in gallbladder carcinoma

23 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Loss of heterozygosity of chromosome 16q in gallbladder carcinoma.

23 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct

23 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

Targeted medical therapy of biliary tract cancer: recent advances and future perspectives

23 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.SURONC.2010.09.003

23 July 2024

Identifiers

1 reference

23 August 2017

1 reference